Reported 1 day ago
In a recent episode of Mad Money, Jim Cramer endorsed Astera Labs (NASDAQ:ALAB) as a worthwhile investment, citing its strong management and growth potential despite a decline in stock value. Cramer highlighted ongoing concerns in the drug distribution sector tied to regulatory pressures, indicating he prefers stocks with better prospects for returns, especially in the AI domain, while noting that Astera Labs offers valuable semiconductor solutions crucial for cloud and AI systems.
Source: YAHOO